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Abstract
Background: Kaposi sarcoma-associated herpesvirus (KSHV) seropositivity is associated with sexual, environmental,
and socioeconomic exposures. Whether these characteristics are independent risk factors is uncertain because of
reliance on selected high-risk or hospital-based populations and incomplete adjustment for confounding. Therefore,
we evaluated risk factors for KSHV seropositivity in a population-based study in Uganda using principal components
analysis (PCA).
Methods: The study population comprised 2,681 individuals randomly selected from a nationally-representative
population-based HIV/AIDS sero-behavioral survey conducted in 2004/05. Questionnaire and laboratory data
(97 variables) were transformed into a smaller set of uncorrelated variables using PCA. Multivariable logistic
regression models were fitted to estimate odds ratios and 95% confidence intervals for the association between
components and KSHV seropositivity.
Results: Data were reduced to three principal components (PCs) labeled as Sexual behavioral, Socioeconomic, and
Knowledge PCs. In crude analysis, KSHV seropositivity was associated with the Knowledge (ptrend = 0.012) and
Socioeconomic components (ptrend = 0.0001), but not with the Sexual-behavioral component (ptrend = 0.066). KSHV
seropositivity was associated with the Socioeconomic PC (ptrend = 0.037), but not with the Sexual-behavioral and
Knowledge PCs, in the models including PCs, age, gender and geographic region.
Conclusions: Our results fit with the view that in Uganda socioeconomic characteristic may influence KSHV
seropositivity. Conversely, the results fit with the interpretation that in Uganda sexual-behavioral characteristics, if
relevant, contribute minimally.
Keywords: Kaposi sarcoma-associated herpesvirus, Uganda, Kaposi sarcoma, Socioeconomic, Principal Components
Analysis, Human herpesvirus 8
Background
Kaposi sarcoma-associated herpesvirus (KSHV) also called
Human herpesvirus 8 (HHV-8), discovered in 1994 in
Kaposi sarcoma (KS) tissue from an AIDS patient [1],
is the infectious cause of KS [2]. In addition to KS, KSHV
also is linked to primary effusion lymphoma (PEL), a rare
aggressive serous cavity lymphoma [3], and to Castleman’s
disease, a benign lymphoproliferative disorder [4]. In 2010,
KSHV was declared a Group 1 carcinogenic agent, high-
lighting its public health significance in countries where it
is endemic [5].
KSHV seropositivity is highest (>50-80%) in equato-
rial Africa [6,7], including in Uganda, where 1 in every 2
persons is KSHV seropositive by adult age [8,9]. KSHV
seropositivity is intermediate (10%) in Mediterranean
Europe [10] and rare (<3%) in the North America and
Northern Europe [11,12], except among homosexual men
in whom up to 1 in every 3 men may be KSHV seroposi-
tive, most likely due to transmission via sexual contact
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[13]. In KSHV endemic regions, KSHV transmission is as-
sociated with casual contact between an infected mother,
sibling, or other family member [14-16], particularly in
children, and with poor socioeconomic status [14]. Trans-
mission may occur via contact with KSHV in saliva in
crowded poor households [15]. Interestingly, KSHV sero-
positivity increases with age in endemic regions, indicating
that sexual transmission may occur, although this might
also be due to virus reactivation later in life increasing de-
tection of antibodies [17]. KSHV seropositivity has been
positively associated with some sexual risk factors such as
number of marital unions and number of children born in
some studies [8,18], but not with other sexual risk factors
such as ever had other STIs in other studies [19,20]. The
validity and/or independence of associations of KSHV se-
ropositivity with sexual, socioeconomic, and family char-
acteristics is uncertain because those findings were based
on studies conducted in hospital-based populations [21],
individuals with sexually transmitted diseases or commer-
cial sex workers [18,20,22] or selected occupational groups
[23], whose results may not be generalized.
We previously showed statistically significant positive
association between KSHV seropositivity and male gen-
der, increasing age, low or no formal education, and resi-
dence in a KS endemic geographical area in Uganda [8],
using data from a nationally representative population-
based sample of adults in Uganda [8,9]. In a follow-up
analysis of the same subjects, KSHV seropositivity was
positively associated with number of marital unions, num-
ber of children born, and inversely associated with having
ever used a condom [9], possibly implicating sexual trans-
mission. However, KSHV seropositivity was not associated
with human herpes simplex 2 (HSV2), human immu-
nodeficiency virus (HIV) infections and other sexual va-
riables, casting doubt on the significance of heterosexual
sexual KSHV transmission in this population. Nonethe-
less, as this study evaluated only 18 of 97 variables for
association with KSHV seropositivity, confounding or non-
specificity of associations could not be excluded [8,23].
In this paper we conducted a principal components
analysis (PCA), an agnostic data reduction method that
allows us to construct underlying exposure components
on the cohort using data from 97 variables collected in
the original Uganda HIV/AIDS sero-behavioral survey
(UHSBS) [24] in 2004/05 study to evaluate associations
with KSHV seropositivity in Uganda.
Results
We identified three independent principal components
(PCs), which were labeled descriptively as Sexual beha-
vioral, Socioeconomic, and Knowledge PCs (Table 1).
Variables contributing to the “Sexual behavioral” PC in-
cluded ever had received blood transfusion, tested for
HIV positive, tested for HSV positive, number of children,
being currently married, and not using a condom during
the last sex intercourse. Variables contributing to the “So-
cioeconomic” PC included wealth index, non-mud based
flooring material, higher education status, owning a radio,
telephone, bicycle, or car (ownership of communication
device or transportation method), having electricity ac-
cess, and ownership of durable goods. Variables contribut-
ing to the “Knowledge” PC included can people avoid or
reduce the chance of getting AIDS by avoid having sex
with homosexual, getting mosquito bites, kissing and get-
ting protection from traditional healer.
In unadjusted analyses (Table 2), KHSV seropositivity
was significantly associated with Socioeconomic (ptrend =
0.0001) and Knowledge (ptrend = 0.012) PCs, but it was
not associated with the Sexual behavioral PC (ptrend =
0.07). Higher scores on the Socioeconomic and Know-
ledge PCs were associated with lower KSHV seropositivity.
The association of KSHV seropositivity with the Socioeco-
nomic (ptrend = 0.002) and Knowledge (ptrend = 0.018) PCs
remained significant when we adjusted for age, sex and
geographical area of residence. The category-specific ORs
between KSHV seropositivity and the Knowledge and Sex-
ual behavioral, but not Socioeconomic, PCs were substan-
tially attenuated or the effect was reversed in some cases
when we adjusted associations for the PCs, suggesting that
the crude associations with these PCs were confounded.
KSHV seropositivity was significantly associated with the
Socioeconomic PC, but not with Knowledge PC when the
PCs were entered into a multivariable model that also in-
cluded age, sex, and geographical region (ptrend =0.038).
When we tested for goodness-of-fit, a multivariable in-
cluding the Socioeconomic PC fit the data better than mo-
dels including the Knowledge and Sexual behavioral PCs
(log-likelihood p < 0.0001).
Discussion
We found that in Uganda, where KSHV is highly en-
demic, KSHV seropositivity was inversely associated with
high factor scores on the Socioeconomic and Knowledge
PCs, but not with Sexual behavioral PC. The association
remained significant when we adjusted for sex, age, and
geographical regions, which were considered confoun-
ders of KSHV seropositivity in this population [12], sug-
gesting that the findings may be valid.
Our study results are generally consistent with pre-
vious studies, which have suggested role of socioecono-
mic status in KSHV seropositivity in Uganda, based on a
study which also used a factor analysis approach [14]. In
that study, KSHV seropositivity was inversely associated
with low factor scores of maternal and environmental
factors, which are surrogates for socioeconomic status.
However, that study was based on hospital-based po-
pulation and relatively limited number of covariates that
was available for adjustment. Our results, from a much
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larger population-based sample that is geographically rep-
resentative of the Ugandan population, confirm the role of
socioeconomic status in KSHV seropositivity in Uganda.
The null association with the Sexual behavioral PC does
not support an important role of sexual behavior on
KSHV seropostivity in the general population in Uganda.
This conclusion is different from the one reached by Shebl
et al. [9] Although KSHV seropositivity was not associated
with HIV or HSV2 infections, with lifetime number of
sexual partners, having at least one sexually transmitted
Table 1 Factor loadings from principal components analysis of UHSBS data years in 2004-2005a
Principal componentsb
Variables Sexual behavioral Socioeconomic Knowledge
Have you ever had a blood transfusion? 0.785 0.013 −0.007
Number of children 0.783 −0.104 0.024
Are you HSV positive? 0.777 −0.031 0.013
Are you HIV positive? 0.775 0.029 0.013
Did you use condom during the last sex intercourse? 0.731 −0.066 0.050
Are you currently married? 0.675 −0.120 −0.003
Number of lifetime sex partners 0.496 0.038 0.001
Occupation 0.404 0.187 0.025
Wealth Index −0.049 0.748 0.043
Use mud as floor material? −0.126 0.701 0.002
Education level −0.176 0.594 −0.009
Ownership of communication device −0.027 0.522 0.068
Ownership of durable good? −0.029 0.505 0.043
Electricity access? −0.127 0.487 0.017
What type of toilet does your household have? −0.090 0.457 0.011
Ethnicity-Baganda 0.031 0.435 −0.062
Use of bednet? −0.047 0.402 0.014
Would you buy vegetables from a vendor had AIDS? 0.053 0.401 −0.058
Have you heard of any drugs that can PROLONG THE LIFE of a
person who has the virus?
0.165 0.383 −0.068
Are there any special drugs that a doctor or nurse can give to
pregnant women infected with AIDS to reduce the risk of transmission?
0.099 0.370 −0.051
Should a HIV-infected female teacher be allowed to teach in school? 0.128 0.362 −0.057
Source of water? −0.015 0.352 −0.008
cBy avoiding sex with homosexual? 0.022 −0.140 0.909
cBy avoiding mosquito bites? −0.016 0.120 −0.798
cBy avoiding kissing? −0.031 0.098 −0.845
cBy protection from traditional healer −0.030 0.149 −0.898
By avoiding partners who have many partners? −0.020 −0.075 0.687
By avoiding sex prostitute? 0.035 −0.068 0.682
By avoiding blood transfusions? −0.047 0.055 0.587
By asking partner to get tested? −0.010 0.011 0.495
By avoiding injections? −0.054 0.021 0.446
By limit number of sex partners? 0.085 0.007 0.418
By avoid sharing razor blades with AIDS patients? −0.151 0.085 0.311
Are you a Christian? −0.020 −0.255 0.051
Are you a Muslim? 0.001 0.265 −0.060
Are you currently divorced? 0.048 −0.031 0.001
a Only showing 35 out of 74 variables; b These components were labeled descriptively to reflect variables with high component loadings; c Can people avoid or
reduce the chance of getting AIDS by these routes.
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disease were unrelated to KSHV seropositivity, it was in-
versely associated with ever use of condom use and po-
sitively associated with being married and with each
additional child born, suggested a possible, albeit, small
role of sexual transmission. Our study found a marginal
association between the Sexual behavior PC and KSHV
seropositivity in crude analyses, but the association disap-
peared after adjusting for the other PCs, suggesting
that the association detected with sexual variables may be
due to confounding by other poorly understood socioeco-
nomic factors.
While our results should not be interpreted as proving
the lack of KSHV transmission via sexual contact, they
support conclusions reached in other studies that that
sexual transmission of KSHV is not a major source of
infection in the general population [20,25,26]. KSHV se-
ropositivity varies substantially by geography at a global
as well local level. For example, de Sanjose and collea-
gues [26] observed significant variation in KSHV sero-
prevalence from 3.8% in Spain to 46% in Nigeria among
women participating in a large international study con-
ducted by the International Agency for Research on Can-
cer. KSHV seropositivity is lower in wealthier countries
in Africa, such as South Africa, and higher in poorer
countries, such as Uganda [25-27]. Within countries,
KSHV seropositivity is higher in rural areas but lower
in urban areas [28,29]. The biological basis of this vari-
ation is presently unclear to us. Our results suggest that
variation in socioeconomic status may play a role in the
geographical variation of KSHV seropositivity [14,26,28].
We previously hypothesized that infection with stool pa-
rasites, which is highly prevalent in poor countries, may
play a role in KSHV transmission [30,31]. Findings by
Lin et al. that KS patients attending the Uganda Can-
cer Institute were more likely to have a higher carriage of
Strongyloides parasites than patients with other cancers
treated at the same hospital [30] provide some support for
the hypothesis. The hypothesis was also supported by a
study of mother-infant pairs in Uganda [31], which re-
ported that detection of malaria parasitaemia, hookworm
and Mansonella perstans in stool was associated KSHV
seropositivity. However, KSHV was not associated with
some other parasites evaluated in the same study, in-
cluding Schistosoma mansoni, Strongyloides stercoralis,
Trichuris trichiura, Ascaris lumbricoides and Trichos-
trongylus species, suggesting that the role of parasites
in the geographical variation of KSHV seropositivity re-
quires further evaluation.
Table 2 Seroprevalence and association between KSHV seropositivity and Principal components (PCs) by quartile
Principal components KSHV seropositivity Univariate Multivariablea Full multivariable modelb
% 95% CI OR 95% CI OR 95% CI OR 95% CI
Sexual behavioral
1st quartile 49.2 50.0, 54.4 Ref Ref Ref Ref Ref Ref
2nd quartile 56.6 51.5, 61.6 1.35 1.01, 1.80 1.11 0.82, 1.51 1.08 0.79, 1.46
3rd quartile 56.7 51.9, 61.7 1.36 1.02, 1.80 1.06 0.77, 1.45 1.02 0.73, 1.42
4th quartile 56.2 51.5, 60.9 1.33 1.01, 1.73 0.95 0.69, 1.32 0.96 0.68, 1.35
P value for heterogeneity 0.106 0.10 0.74 0.89
P value for trend 0.066 0.61 0.58
Socioeconomic
1st quartile 61.6 57.3, 65.9 Ref Ref Ref Ref Ref Ref
2nd quartile 56.8 52.2, 61.4 0.82 0.65, 1.05 0.85 0.67, 1.08 0.87 0.67, 1.14
3rd quartile 48.8 43.7, 53.9 0.60 0.46, 0.78 0.61 0.47, 0.81 0.68 0.49, 0.92
4th quartile 50.6 45.4, 55.8 0.64 0.49, 0.84 0.67 0.50, 0.91 0.78 0.54, 1.13
P value for heterogeneity 0.0003* 0.0004* 0.005 0.095
P value for trend 0.0001* 0.002* 0.037*
Knowledge
1st quartile 59.9 55.5, 64.4 Ref Ref Ref Ref Ref Ref
2nd quartile 55.5 50.0, 60.9 0.83 0.63, 1.11 0.85 0.64, 1.14 1.00 0.74, 1.36
3rd quartile 47.7 42.8, 52.5 0.61 0.47, 0.79 0.63 0.48, 0.82 0.76 0.57, 1.02
4th quartile 54.4 49.8, 58.9 0.80 0.62, 1.02 0.80 0.63, 1.03 0.96 0.74, 1.25
P value for heterogeneity 0.004* 0.003* 0.006* 0.18
P value for trend 0.012* 0.018* 0.49
a. Adjusted for age, sex, geographical region; b. Adjusted for age, sex, and geographical region and other PCs; * p-value < 0.0.
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Strengths and limitations
The strengths of our study include having detailed data
on a nationally representative sample, which enabled us
to use PCA methods to evaluate associations with KSHV
seropositivity. Exclusion of variables where prior studies
indicated significant associations enabled us to confirm
those previous associations after taking into account all
available data. PCA has the ability to identify independ-
ent factors that explain the maximum amount of mutual
correlation [32]. However, our findings should be inter-
preted with caution. First, while the PCA methods offer
a parsimonious way to transform many correlated vari-
ables into a few uncorrelated variables, it may mask rele-
vant associations. For instance, some sexual behavioral
variables such as ever used condom from the last sex
intercourse or number of children born were found to
be associated with KSHV seropositivity [9], but PCA does
not reveal this association. Moreover, since PCA is sum-
ming up across errors in data collection, data entry and
laboratory testing, some contradictory patterns can be
found compared to previous findings. Second, our data
are cross-sectional; therefore, it is not possible to deter-
mine the direction of causality. Third, KSHV serology is
imperfect [33], thus, misclassification of results, although
it would be random, is possible.
Conclusions
To summarize, we report a significant association bet-
ween low socioeconomic status and KSHV seropositivity.
Sexual behavioral and Knowledge PCs were unrelated
to KSHV seropositivity. Future work is needed to bet-
ter understand how socioeconomic exposures influence
KSHV transmission in countries where KSHV and KS are
endemic.
Materials and methods
Ethical approval
The Uganda Virus Research Institute (UVRI) Science
Ethics Committee and the National Council of Science
and Technology in Uganda and from the Centers for
Disease Control and Prevention (CDC, Atlanta, Georgia,
USA) gave ethical approval to conduct the study.
Study population
Details of this study have been previously reported
[8,9,34,35]. Briefly, the study was based on a subset of
data from the original 19,656 Ugandans aged 15–59 years
enrolled the UHSBS in 2004–2005 to investigate national
and subnational patterns of HIV/AIDS in Uganda [34,35].
The UHSBS used a two-stage cluster probability sample
design to obtain a nationally representative sample of
adults. In the first stage, 417 clusters were selected from
census enumeration areas of the 2002 Uganda National
Census [36]. In the second stage, 25 households were
randomly selected per cluster. All adult residents in
the household were invited to participate, for a total
sample size of 10,437 individuals.
The KSHV studies are based on 2,681 individuals ran-
domly selected from the original UHSBS sample and
tested for KHSV serologically [8,9]. Detailed descriptions
of the Uganda cohort and blood sampling technique have
been described in previous studies [8,9].
KSHV serology and testing
KSHV serology was performed at UVRI in Uganda using
synthetic peptides encoded by K8.1 and orf65 viral genes
manufactured at the CDC Herpes Virology Laboratory
in Atlanta [37,38]. The qualities of KSHV serology at
UVRI and the CDC were comparable, based on parallel
testing of a panel of well characterized samples subjects
with KS, asymptomatic Ugandans, and HIV positive and
negative Caucasians provided by the National Cancer
Institute (Spearman’s rank correlation coefficients for op-
tical density (OD) values = 0.86 for K8.1 and OD= 0.78 for
orf65, both p < 0.001). Although KSHV serology remains
imperfect, the combined assays have a sensitivity of about
93% [38] and a specificity of about 98% [39] in African
samples. KSHV results were categorized as positive when
the adjusted K8.1 OD was >0.7 or 0.5-0.7 and the adjusted
orf65 OD was >2.5, negative when the adjusted K8.1 OD
was 0.5-0.7 and the adjusted orf65 OD was ≤2.5, and inde-
terminate when the adjusted K8.1 OD was 0.5-0.7 and the
orf65 OD was <2.5.
Data and variables
Detailed analyses of KSHV seropositivity patterns have
been assessed and described in previous studies [8,9]. To
observe the complete pattern of KSHV seropositivity in
Uganda, this study included all questions were asked in
the UHSBS including questions with knowledge and at-
titudes on HIV/AIDS and additional household ques-
tions, which was not elicited described in previous studies
[8,9,34,35].
The data included information from household (18
variables) and individual (76 variables) questionnaires
and from results of laboratory tests (3 variables: HIV,
HSV2 (all subjects) and hepatitis B virus (HBV) (available
on the same random1/3 subsample of subjects)). The hou-
sehold questionnaire elicited information on ownership of
durable goods, car, motorcycle or bicycle, television, mo-
bile phone and landline phone, mosquito bed net, source
of drinking water (surface, well/public, well/private, piped/
private), type of material used to build the floor, source
of electricity, and type of toilet used (none, uncovered pit,
covered pit, or flush toilet). The individual questionnaire
elicited information on demographic information, know-
ledge and attitudes about how HIV may be transmitted
or not and their knowledge about correct and incorrect
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routes of HIV/AIDS, their attitudes toward people who
may have HIV/AIDS. For example, demographic informa-
tion includes level of education attained, current occu-
pation, ethnicity, religion, number of children born, and
current marital status. Questions about knowledge and
attitudes about HIV transmission include “can people
avoid or reduce the chances of getting AIDS or the virus
that causes AIDS by avoiding mosquito bites?”, or “can
people avoid or reduce the chances of getting AIDS or the
virus that causes AIDS by using condom during sex?”;
questions about their attitudes toward people who may
have HIV/AIDS include “would you take care of a relative
who is living with AIDS?”, or “should a HIV-infected fe-
male teacher be allowed to teach in school?”.
Statistical methods
Principal Components are linear combinations of the in-
put variables and explain as much of the variation in the
data as possible [32]. Large positive or negative factor
loadings indicate the variable that is more representative
in that component. Factor loadings with a magnitude at
least 0.3 were used to describe the component.
Statistical analyses were performed in SAS version 9.2
using PROC FACTOR procedure (SAS Institute, Cary,
NC, USA). Analysis utilized available data from 97 varia-
bles collected during the UHSBS. PCA was utilized to
transform the 97 correlated variables in the dataset into
a smaller set of uncorrelated variables (Figure 1) [32].
Because age, gender, and geographic region were prev-
iously shown to be significantly associated with KSHV
seropositivity [22], they were excluded from the PCA.
To avoid redundancy, Pearson correlations of all pairs of
94 variables were computed, and when the correlation
coefficients were greater than 0.90, only one of the two
variables was chosen to be included in the PCA. The
chosen variable was the one with less missing values. In
addition, if the sample size were similar, variable with
less correlation was selected. This resulted in exclusion
of 21 variables. Thus, 76 representative variables were
retained for PCA. The PCs were identified, based on the
patterns of the Scree plots. Three PCs were identified
97 variables including questions about sexual behaviors, socioeconomic status, sexual 
knowledge, and environmental exposure
Exclude age, sex and 
regions
94 variables including questions about sexual behaviors, socioeconomic status, sexual 
knowledge, and environmental exposure
Exclude highly correlated 
variables
76 variables including questions about sexual behaviors, socioeconomic status, sexual 
knowledge, and environmental exposure
Principal Component Analysis
Sexual behavioral 
component
Socioeconomic
component
Knowledge
component
Figure 1 Flow chart showing data reduction approach applied to household- and individual-questionnaire variables and laboratory
results during principal components analysis.
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from and the resulting PCs were transformed into uncor-
related through orthogonal rotation (varimax). The PCs
were labeled descriptively based on the variables with high
factor loadings (>0.3).
The association between PCs and KSHV seropositivity
was evaluated by entering PCs, PC scores were compu-
ted for each individual and were divided into quartiles
to create categorical variables. The odds ratios (ORs)
and 95% confidence intervals (CIs) were used to esti-
mate the association between KSHV seropositivity and
the PCs. The logistic regression analyses were weighted
for the sample and accounted for the cluster sampling
of the UHSBS using the SAS survey procedure PROC
SURVEYLOGISTIC. Age, gender, and geographic loca-
tion, which were not included in the derivation of PCs but
were considered a priori established risk factors for KSHV
seropositivity [7], were entered as covariates in logistic re-
gression to adjust for potential confounding of the asso-
ciation between PCs and KSHV seropositivity. 2-sided
p-values were obtained using the Rao-Scott tests [40] were
considered statistically significant if less than 0.05.
Consent
Written informed consent was obtained for the patient
for publication of this report.
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